Who owns Rigel Pharmaceuticals?

Key details on Rigel Pharmaceuticals (Ticker: RIGL)

Who owns Rigel Pharmaceuticals?

Is RIGL a good stock to own? Find out who bought Rigel Pharmaceuticals, who sold Rigel Pharmaceuticals (RIGL) stock, and who holds a large position in Rigel Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
FMR 13.17M $25.55M Sept. 30, 2014
Wellington Management Company 6.16M $22.35M June 30, 2014
Broadfin Capital 5.60M $20.32M June 30, 2014
Palo Alto Investors 5.18M $10.05M Sept. 30, 2014
OppenheimerFunds 5.00M $9.70M Sept. 30, 2014
T. Rowe Price Associates 4.61M $16.51M Sept. 30, 2013
Vanguard 3.73M $7.23M Sept. 30, 2014
BlackRock Institutional Trust Company, N.A. 3.32M $6.44M Sept. 30, 2014
NEA Management Company 3.24M $6.29M Sept. 30, 2014
BlackRock Fund Advisors 3.17M $6.15M Sept. 30, 2014
Millennium Management 3.06M $5.93M Sept. 30, 2014
BVF 2.58M $10.00M March 31, 2014
Deerfield Management Company 2.40M $4.65M Sept. 30, 2014
STATE STREET CORPORATION 2.27M $14.74M Dec. 31, 2013
SENZAR ASSET MANAGEMENT 2.07M $4.02M Sept. 30, 2014
Visium Asset Management 2.01M $5.73M Dec. 31, 2013
UBS GLOBAL ASSET MANAGEMENT AMERICAS 1.99M $3.85M Sept. 30, 2014
HealthCor Management 1.80M $14.49M March 31, 2012
D. E. Shaw & Co 1.65M $6.01M June 30, 2014